Search

Search Constraints

You searched for: Author/Creator Bilici, Ahmet

Search Results

1. Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade. (September 2019)

2. Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer. Issue 4 (27th January 2022)

3. Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group. Issue 50 (16th December 2022)

4. Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non‐small‐cell lung cancer. (28th November 2019)

5. Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study. (21st April 2017)

7. Malignancies Diagnosed During Pregnancy and Treated With Chemotherapy or Other Modalities (Review of 27 Cases): Multicenter Experiences. Issue 5 (1st June 2010)

10. Platelet to lymphocyte ratio is associated with tumor localization and outcomes in metastatic colorectal cancer. Issue 44 (5th November 2021)